108 related articles for article (PubMed ID: 26125710)
1. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
[TBL] [Abstract][Full Text] [Related]
2. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
3. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
4. The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(16):6923-8. PubMed ID: 25169547
[TBL] [Abstract][Full Text] [Related]
5. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
Sergentanis TN; Economopoulos KP
Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
11. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
13. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
14. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
15. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
Li J; Luo F; Zhang H; Li L; Xu Y
Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
Zhang YJ; Chen SY; Chen CJ; Santella RM
Mol Carcinog; 2002 Feb; 33(2):125-9. PubMed ID: 11813305
[TBL] [Abstract][Full Text] [Related]
17. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
18. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
[TBL] [Abstract][Full Text] [Related]
19. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
Cai W; Wang ZT; Zhong J; Zhang Y
Genet Mol Res; 2013 Apr; 12(4):6636-45. PubMed ID: 23661400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
